UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors

PloS one, 2015-12, Vol.10 (12), p.e0144787-e0144787

2015

Volltextzugriff (PDF)

Survival of the Strong and Dense: Field Evidence for Rapid, Transport‐Dependent Bed Material Abrasion of Heterogeneous Source Lithology

Journal of geophysical research. Earth surface, 2022-06, Vol.127 (6), p.n/a

2022

Volltextzugriff (PDF)

Wrestling with a ghost: facing an opponent I can neither see nor clinch – the experience of professional wrestlers who have suffered an ACL injury

BMJ Open Sport & Exercise Medicine, 2024, Vol.10 (1), p.e001782-e001782

2024

Volltextzugriff (PDF)

Approaches to augment CAR T-cell therapy by targeting the apoptotic machinery

Biochemical Society transactions, 2016-04, Vol.44 (2), p.371-376

Karlsson, Hannah

2016

Volltextzugriff (PDF)

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Clinical cancer research, 2018-12, Vol.24 (24), p.6185-6194

2018

Volltextzugriff (PDF)

CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma

Human gene therapy, 2015-08, Vol.26 (8), p.498-505

2015

Volltextzugriff (PDF)

748. A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Molecular therapy, 2016-05, Vol.24, p.S295-S296

2016

Volltextzugriff (PDF)

CAR T Cells Express CD40L and Activates Human Dendritic Cells

Molecular therapy, 2014, Vol.22, p.S61

2014

Volltextzugriff (PDF)

A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Molecular therapy, 2016, Vol.24, p.S295

2016

Volltextzugriff (PDF)

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Blood, 2015-12, Vol.126 (23), p.1534-1534

2015

Volltextzugriff (PDF)

Antigen Signaling Enhances Proliferation and Cytotoxic Capacity of CD19-Targeting CD28/4-1BB CAR T Cells During Expansion Without Inducing Exhaustion

Molecular therapy, 2014, Vol.22, p.S61

2014

Volltextzugriff (PDF)

Cd19-targeting car t cells for treatment of b cell malignancies: from bench to bedside

Karlsson, Hannah

2014

Volltextzugriff (PDF)

ABT-737 Sensitizes B Cell Tumors for Killing by CD19-Retargeted T Cells

Blood, 2011-11, Vol.118 (21), p.4032-4032

2011

Volltextzugriff (PDF)

CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial

Cancer immunology research, 2016, Vol.4 (1)

2016

Volltextzugriff (PDF)

Abstract A041: CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia – report from the Swedish phase I/IIa trial

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.A041-A041

2016

Volltextzugriff (PDF)

Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy

Cancer gene therapy, 2013-07, Vol.20 (7), p.386-393

2013

Volltextzugriff (PDF)

Immunological biomarkers correlate to survival in CAR19-treated patients

Scandinavian journal of immunology, 2017, Vol.86 (4), p.337

2017

Volltextzugriff (PDF)

High-Density, Long-Lasting, and Multi-region Electrophysiological Recordings Using Polymer Electrode Arrays

Neuron (Cambridge, Mass.), 2019-01, Vol.101 (1), p.21-31.e5

2019

Volltextzugriff (PDF)

Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments

Annual review of chemical and biomolecular engineering, 2018-06, Vol.9 (1), p.105-127

2018

Volltextzugriff (PDF)

Excess risk of SARS‐CoV‐2 infection among in‐person nonhealthcare workers in six states, September 2020–June 2021

American journal of industrial medicine, 2023-07, Vol.66 (7), p.587-600

2023

Volltextzugriff (PDF)

Halting European Union soybean feed imports favours ruminants over pigs and poultry

Nature food, 2021-01, Vol.2 (1), p.38-46

2021

Volltextzugriff (PDF)

Reported Exposures Among In-Person Workers With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in 6 States, September 2020–June 2021

Clinical infectious diseases, 2022-10, Vol.75 (Supplement_2), p.S216-S224

2022

Volltextzugriff (PDF)

Parental inflammatory bowel disease and autism in children

Nature medicine, 2022-07, Vol.28 (7), p.1406-1411

2022

Volltextzugriff (PDF)

Bacterial Factors Required for Transmission of Streptococcus pneumoniae in Mammalian Hosts

Cell host & microbe, 2019-06, Vol.25 (6), p.884-891.e6

2019

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors

Survival of the Strong and Dense: Field Evidence for Rapid, Transport‐Dependent Bed Material Abrasion of Heterogeneous Source Lithology

Wrestling with a ghost: facing an opponent I can neither see nor clinch – the experience of professional wrestlers who have suffered an ACL injury

Approaches to augment CAR T-cell therapy by targeting the apoptotic machinery

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma

748. A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

CAR T Cells Express CD40L and Activates Human Dendritic Cells

A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Antigen Signaling Enhances Proliferation and Cytotoxic Capacity of CD19-Targeting CD28/4-1BB CAR T Cells During Expansion Without Inducing Exhaustion

Cd19-targeting car t cells for treatment of b cell malignancies: from bench to bedside

ABT-737 Sensitizes B Cell Tumors for Killing by CD19-Retargeted T Cells

CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial

Abstract A041: CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia – report from the Swedish phase I/IIa trial

Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy

Immunological biomarkers correlate to survival in CAR19-treated patients

High-Density, Long-Lasting, and Multi-region Electrophysiological Recordings Using Polymer Electrode Arrays

Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments

Excess risk of SARS‐CoV‐2 infection among in‐person nonhealthcare workers in six states, September 2020–June 2021

Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability

Halting European Union soybean feed imports favours ruminants over pigs and poultry

Reported Exposures Among In-Person Workers With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in 6 States, September 2020–June 2021

Parental inflammatory bowel disease and autism in children

Bacterial Factors Required for Transmission of Streptococcus pneumoniae in Mammalian Hosts

Suchergebnisse filtern